ArticleInflammatory bowel diseases2023

Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.

Paul Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.